ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 112 filers reported holding ACCELERON PHARMA INC in Q3 2015. The put-call ratio across all filers is 2.48 and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $34,390,000 | -20.6% | 1,347,553 | +12.6% | 0.01% | -33.3% |
Q3 2016 | $43,321,000 | +13.0% | 1,197,052 | +6.1% | 0.01% | +12.5% |
Q2 2016 | $38,332,000 | +35.7% | 1,128,078 | +5.4% | 0.01% | +14.3% |
Q1 2016 | $28,240,000 | -37.1% | 1,070,110 | +16.2% | 0.01% | -30.0% |
Q4 2015 | $44,904,000 | +83.8% | 920,917 | -6.2% | 0.01% | +66.7% |
Q3 2015 | $24,436,000 | -17.9% | 981,351 | +4.3% | 0.01% | -14.3% |
Q2 2015 | $29,769,000 | -5.2% | 940,872 | +14.1% | 0.01% | 0.0% |
Q1 2015 | $31,389,000 | +1.8% | 824,732 | +4.2% | 0.01% | -12.5% |
Q4 2014 | $30,831,000 | +186.9% | 791,349 | +122.7% | 0.01% | +166.7% |
Q3 2014 | $10,748,000 | -12.7% | 355,415 | -1.9% | 0.00% | 0.0% |
Q2 2014 | $12,312,000 | +78.4% | 362,428 | +81.1% | 0.00% | +50.0% |
Q1 2014 | $6,903,000 | -0.4% | 200,099 | +14.4% | 0.00% | 0.0% |
Q4 2013 | $6,928,000 | – | 174,954 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |